SG Americas Securities, LLC

Broker-Dealer

Position in HUMA — Humacyte, Inc.

CIK 1313360 NEW YORK, NY

Position in HUMA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$34,794

+$22,025 QoQ

Shares Held

44,608

+112.0% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 163 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,086,395,205 across 182 Biotechnology names. HUMA ranks #166 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,794	44,608	+112.0%	Shares	Sole	2026-08-07
2026-03-31	$12,769	21,037	-38.3%	Shares	Sole	2026-04-16
2025-12-31	$32,746	34,075	+50.3%	Shares	Sole	2026-01-09
2025-09-30	$39,435	22,664	-48.5%	Shares	Sole	2025-10-23
2025-06-30	$91,916	43,979	-0.2%	Shares	Sole	2025-08-08
2025-03-31	$75,147	44,075	+12.6%	Shares	Sole	2025-04-15
2024-12-31	$197,672	39,143	+22.0%	Shares	Sole	2025-01-17
2024-09-30	$174,482	32,074	+96.3%	Shares	Sole	2024-10-03
2023-12-31	$46,405	16,340	+52.8%	Shares	Sole	2024-01-12
2023-09-30	$31,336	10,695	-64.3%	Shares	Sole	2023-10-13
2023-03-31	$92,455	29,921	+176.4%	Shares	Sole	2023-04-28
2022-09-30	$35,292	10,826	—	Shares	Sole	2022-10-31
No filing history on record for this holder in this stock.